🟢 20/20 Biolabs is trading 12.42% up today as XBI gains 2.06%

20/20 Biolabs is trading at $0.58, up +12.42%, mainly amid biotechnology-sector strength, with XBI up 2.06% and the Nasdaq Composite up 0.84%.

• No new company-specific announcement or filing dated August 25, 2026 was identified; recent coverage remains focused on the August 17 quarterly report.
• The latest quarterly update showed record OneTest revenue and stronger gross profit, but predates the move and does not establish direct causation.